Ribociclib: RWE-Daten bestätigen PFS-/OS-Vorteile
Abstract
Translate Article 
Take Notes
Ribociclib: RWE-Daten bestätigen PFS-/OS-Vorteile
More from: Breast CareBreast Conservation Therapy vs. Mastectomy Survival in Young Breast Cancer Patients: Systematic Review & Meta-Analysis Prevention of Severe Postoperative Pain after Breast Surgery Using Opioid-Sparing Analgesia with Intraoperative and Drain-Based Ropivacaine Infiltration: A Prospective Observational Study Overall survival in metastatic breast cancer patients: Real world data from 1000 patients treated at the NCT Heidelberg between 2014 and 2022 Macroareolar Changes following Periareolar Mastopexy: A Postoperative Assessment PharmaNews Palbociclib bei HR+/HER2- mBC: Patient*innenbedürfnisse im Fokus Ribociclib: RWE-Daten bestätigen PFS-/OS-Vorteile Investigation of Factors Affecting Histopathological Upgrade in Breast Papillary Lesions: A Single-Center Study Treatment Experience of Early-Stage Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer in a Real-World Setting: European Patients’ Perspectives Microbial Biomarkers of Breast Tumor and Mastitis: Deciphering the Delicate Balance between Potentially “Evil” and “Benign” Alliances in Mammary Microbiomes
- Research Article
- 10.1159/000548895
- Oct 11, 2025
- Breast Care
- Research Article
- 10.1159/000547185
- Oct 9, 2025
- Breast Care
- Research Article
- 10.1159/000548610
- Oct 9, 2025
- Breast Care
- Research Article
- 10.1159/000548681
- Oct 3, 2025
- Breast Care
- Supplementary Content
- 10.1159/000548587
- Oct 1, 2025
- Breast Care
- Supplementary Content
- 10.1159/000548775
- Oct 1, 2025
- Breast Care
- Supplementary Content
- 10.1159/000548776
- Oct 1, 2025
- Breast Care
- Research Article
- 10.1159/000548105
- Sep 27, 2025
- Breast Care
- Research Article
- 10.1159/000547748
- Sep 13, 2025
- Breast Care
- Research Article
- 10.1159/000548037
- Sep 11, 2025
- Breast Care
- Ask R Discovery
- Chat PDF
AI summaries and top papers from 250M+ research sources.